184 related articles for article (PubMed ID: 32266692)
1. The role of diffusion-weighted and dynamic contrast enhancement perfusion-weighted imaging in the evaluation of salivary glands neoplasms.
Pietragalla M; Nardi C; Bonasera L; Mungai F; Taverna C; Novelli L; De Renzis AGD; Calistri L; Tomei M; Occhipinti M; Colagrande S
Radiol Med; 2020 Sep; 125(9):851-863. PubMed ID: 32266692
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.
Zheng N; Li R; Liu W; Shao S; Jiang S
Br J Radiol; 2018 Sep; 91(1089):20170707. PubMed ID: 29902075
[TBL] [Abstract][Full Text] [Related]
3. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer.
Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z
Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829
[TBL] [Abstract][Full Text] [Related]
5. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
[TBL] [Abstract][Full Text] [Related]
6. How to manage type 2 curve dilemma in dynamic contrast-enhanced magnetic resonance imaging of the breast: diffusion-weighted imaging or early phase enhancement kinetics?
Ulu Öztürk F; Tezcan Ş; Uslu N
Acta Radiol; 2024 Apr; 65(4):341-349. PubMed ID: 38193154
[TBL] [Abstract][Full Text] [Related]
7. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
Abdel Razek AA; Samir S; Ashmalla GA
J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
[TBL] [Abstract][Full Text] [Related]
9. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
[TBL] [Abstract][Full Text] [Related]
10. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MRI for differentiation between sialadenitis and pleomorphic adenoma.
Terra GT; Oliveira JX; Hernandez A; Lourenço SV; Arita ES; Cortes AR
Dentomaxillofac Radiol; 2017 Jan; 46(1):20160257. PubMed ID: 27845594
[TBL] [Abstract][Full Text] [Related]
12. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging.
Shao S; Zheng N; Mao N; Xue X; Cui J; Gao P; Wang B
Clin Radiol; 2021 Jun; 76(6):472.e11-472.e18. PubMed ID: 33752882
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
14. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of salivary gland tumours using diffusion-weighted image-based virtual MR elastography: a pilot study.
Jung HN; Ryoo I; Suh S; Kim B; You SH; Kim E
Dentomaxillofac Radiol; 2024 Apr; 53(4):248-256. PubMed ID: 38502962
[TBL] [Abstract][Full Text] [Related]
16. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.
Razek AAKA
Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of various salivary gland tumours using diffusion-weighted MRI and dynamic contrast-enhanced MRI.
Kushwaha M; Kumar J; Garg A; Singh I; Khurana N
Pol J Radiol; 2023; 88():e203-e215. PubMed ID: 37234459
[TBL] [Abstract][Full Text] [Related]
18. Diffusion and perfusion MR patterns of central nervous system lymphomas.
Neska-Matuszewska M; Zimny A; Bladowska J; Sąsiadek M
Adv Clin Exp Med; 2018 Aug; 27(8):1099-1108. PubMed ID: 29975467
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla.
Nguyen VT; Rahbar H; Olson ML; Liu CL; Lehman CD; Partridge SC
J Magn Reson Imaging; 2015 Sep; 42(3):788-800. PubMed ID: 25611726
[TBL] [Abstract][Full Text] [Related]
20. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
